STOCK TITAN
  1. Home
  2. Sec-filings
  3. APVO
  4. [EFFECT] Aptevo Therapeutics Inc SEC Filing

[EFFECT] Aptevo Therapeutics Inc SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
EFFECT
Rhea-AI Filing Summary
Riscrivi il testo seguente:
Reescribe el siguiente texto:
다음 텍스트를 다시 작성하세요:
Réécrivez le texte suivant :
Schreiben Sie den folgenden Text um:
Positive
  • None.
Negative
  • None.
Riscrivi il testo seguente:
Reescribe el siguiente texto:
다음 텍스트를 다시 작성하세요:
Réécrivez le texte suivant :
Schreiben Sie den folgenden Text um:
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: June 18, 2025 9:00 A.M.
Form: S-1
CIK: 0001671584
Company Name: Aptevo Therapeutics Inc.
File Number: 333-288061

Source: View Original Filing on SEC EDGAR

Stock APVO logo
Aptevo Therapeutics Inc

NASDAQ:APVO

APVO Rankings

#10549 Ranked by Market Cap
N/A Ranked by Dividends

APVO Latest News

Jun 20, 2025
Aptevo Therapeutics Announces Closing of $8 Million Offering Priced At-the-Market Under Nasdaq Rules
Jun 20, 2025
Aptevo Expands Differentiated CD3 Portfolio with APVO455, Advancing a Suite of Targeted T-cell Engagers
Jun 18, 2025
Aptevo Therapeutics Announces $8 Million Offering Priced At-the-Market Under Nasdaq Rules
Jun 18, 2025
Mipletamig Demonstrates Compelling Clinical Activity in Frontline AML
Jun 13, 2025
Aptevo Participating in the BIO International Convention

APVO Latest SEC Filings

Jul 9, 2025
[Form 3] Aptevo Therapeutics Inc Initial Statement of Beneficial Ownership
Jul 8, 2025
[SCHEDULE 13G] Aptevo Therapeutics Inc SEC Filing
Jul 7, 2025
[DEF 14A] Aptevo Therapeutics Inc Definitive Proxy Statement
Jul 3, 2025
[ARS] Aptevo Therapeutics Inc SEC Filing
Jul 1, 2025
[8-K] Aptevo Therapeutics Inc Reports Material Event

APVO Stock Data

8.31M
3.22M
0.01%
4.85%
4.12%
Biotechnology
Pharmaceutical Preparations
Link
United States
SEATTLE